Sun Pharmaceutical Industries has an EPS of $35.3. In 2022, the company made an earnings per share (EPS) of $13.6. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
Year | EPS | Change |
---|---|---|
2023 | $35.30 | 159.56% |
2022 | $13.60 | 12.40% |
2021 | $12.10 | -22.93% |
2020 | $15.70 | - |